Thrombectomy Devices Market By Technology (Mechanical Thrombectomy, Aspiration Thrombectomy, Rheolytic Thrombectomy), By Type (Automated Devices, Manual Devices), By Utility (Reusable Devices, Disposable Devices), By Application (Peripheral Diseases, Coronary Disease, Neural Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030

Thrombectomy Devices Market

Thrombectomy devices assist surgeons to remove blood clot from veins or arteries of the patient. These devices are efficient in treating blood clots in veins and arteries compared to other methods of clot management.

High occurrence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE) and rise in sedentary and unhealthy lifestyle drives the thrombectomy devices market growth. In addition, rise in healthcare infrastructure, increase in demand for minimally-invasive treatments, surge in geriatric population, growth in competition among key players, and technological advancements & innovations drive the thrombectomy devices market trends. For instance, in September 2021, Abbott, a pharmaceutical company, announced the acquisition of maker walk vascular, which is the mechanical thrombectomy device. Walk vascular offers JETi peripheral systems that helps to remove intravascular clots called a thrombus, which may minimize blood flow and lead to serious complications for patients. Moreover, in June 2021, AngioDynamics, a medical technology company, announced the U.S. Food and Drug Administration (FDA) clearance for alphaVac mechanical thrombectomy system, which is an off-circuit, multi-purpose mechanical aspiration thrombectomy device. It is used for the non-surgical removal of thrombi or emboli from the vasculature. Thus, increase in number of approval for thrombectomy devices, and increase in demand for thrombectomy device, surge the growth of thrombectomy devices industry. Unavailability of trained professionals, lack of awareness about thrombectomy devices, and complicated use of thrombectomy devices hinder the growth of the thrombectomy devices market share.

Thrombectomy devices market is segmented on the basis of technology, type, utility, application, and region. Depending on technology, it is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. According to type, it is divided into automated devices and manual devices. As per the utility, it is bifurcated into reusable devices and disposable devices. By application, it is categorized into peripheral diseases, coronary diseases, and neural diseases. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Region-wise, North America dominated the thrombectomy device market in 2020, and is expected to be dominant during the forecast period, owing to growth in advanced health care facility, rise in prevalence of neurological disorder, increase in number of approvals for thrombectomy devices, surge in number of surgical procedures, and rise in presence of key players in thrombectomy devices industry. However, Asia-Pacific is expected to register highest CAGR of 8.8% from 2021 to 2030, owing to growth in patient population, increase in government insurance coverage in developing countries, increase in prevelnce of cardiovascular disesaes and rise in approvals of new innovative embolization and mechanical thrombectomy products.

The COVID-19 outbreak negatively impacted the thrombectomy device market. The COVID-19 pandemic hampered healthcare systems across the globe. Surgical procedures are affected by COVID-19 pandemic. Several clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to COVID-19 outbreak declined the number of elective surgeries performed across the globe.

KEY FINDINGS OF THE STUDY

By technology, the mechanical thrombectomy device segment was the highest contributor to the market in 2020.

On the basis of type, the manual thrombectomy device segment dominated the market in 2020, and is expected to continue this trend during the forecast period.

On the basis of utility, the disposable thrombectomy device segment dominated the market in 2020, and is expected to continue this trend during the forecast period.

On the basis of application, neural disease segment dominated the market in 2020, and is expected to continue this trend during the forecast period.

Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The global thrombectomy device market was valued at $1,269.0 million in 2020, and is projected to reach $2,567.5 million by 2030, registering a CAGR of 7.4% from 2021 to 2030. Thrombectomy device is  used to treat blood clots, which are present in capillaries, veins, and arteries. Surgical thrombectomy is a procedure, which  removes blood clot from an artery or vein that obstructs blood flow. Thrombectomy devices minimize the damage that  can be caused to blood vessels during procedure and reduce blood loss. These devices are available according to affected areas, in different sizes, and diameters. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

The key factors that drive the market growth include, increase in incidence of cardiovascular disease, rise in unhealthy living conditions and habits in young generation, and surge in geriatric population. Increase in incidence of neurological disorder, surge in demand for minimally invasive procedures, development of healthcare infrastructure, and rise in competition among key player for development of thrombectomy device propel the growth of the market. In addition, increase in technological advancements and innovations for development of advanced thrombectomy device surge the growth of the market.

Thrombectomy devices market is segmented on the basis of technology, type, utility, disease, and region. Depending  on technology, it is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. By type, it is divided into automated devices and manual devices. According to utility, it is bifurcated into reusable devices and disposable devices. As per disease, it is categorized into peripheral diseases, coronary diseases, and neural diseases

Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include AngioDynamics, Inc., Johnson & Johnson, Inc., Penumbra Inc., Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc., Stryker Corporation, and Teleflex Incorporated

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the thrombectomy devices market analysis from 2020 to 2030 to identify the prevailing thrombectomy devices market opportunity.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the thrombectomy devices market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global thrombectomy devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

Terumo Corporatio

Scope of Thrombectomy Devices Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Mechanical Thrombectomy

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Aspiration Thrombectomy

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Rheolytic Thrombectomy

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Automated Devices

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Manual Devices

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Reusable Devices

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Disposable Devices

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 Peripheral Diseases

7.2.1 Key market trends, growth factors and opportunities

7.2.2 Market size and forecast, by region

7.2.3 Market analysis by country

7.3 Coronary Disease

7.3.1 Key market trends, growth factors and opportunities

7.3.2 Market size and forecast, by region

7.3.3 Market analysis by country

7.4 Neural Diseases

7.4.1 Key market trends, growth factors and opportunities

7.4.2 Market size and forecast, by region

7.4.3 Market analysis by country

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key trends and opportunities

8.2.2 North America Market size and forecast, by Technology

8.2.3 North America Market size and forecast, by Type

8.2.4 North America Market size and forecast, by Utility

8.2.5 North America Market size and forecast, by Application

8.2.6 North America Market size and forecast, by country

8.2.6.1 U.S.

8.2.6.1.1 Market size and forecast, by Technology

8.2.6.1.2 Market size and forecast, by Type

8.2.6.1.3 Market size and forecast, by Utility

8.2.6.1.4 Market size and forecast, by Application

8.2.6.2 Canada

8.2.6.2.1 Market size and forecast, by Technology

8.2.6.2.2 Market size and forecast, by Type

8.2.6.2.3 Market size and forecast, by Utility

8.2.6.2.4 Market size and forecast, by Application

8.2.6.3 Mexico

8.2.6.3.1 Market size and forecast, by Technology

8.2.6.3.2 Market size and forecast, by Type

8.2.6.3.3 Market size and forecast, by Utility

8.2.6.3.4 Market size and forecast, by Application

8.3 Europe

8.3.1 Key trends and opportunities

8.3.2 Europe Market size and forecast, by Technology

8.3.3 Europe Market size and forecast, by Type

8.3.4 Europe Market size and forecast, by Utility

8.3.5 Europe Market size and forecast, by Application

8.3.6 Europe Market size and forecast, by country

8.3.6.1 Germany

8.3.6.1.1 Market size and forecast, by Technology

8.3.6.1.2 Market size and forecast, by Type

8.3.6.1.3 Market size and forecast, by Utility

8.3.6.1.4 Market size and forecast, by Application

8.3.6.2 France

8.3.6.2.1 Market size and forecast, by Technology

8.3.6.2.2 Market size and forecast, by Type

8.3.6.2.3 Market size and forecast, by Utility

8.3.6.2.4 Market size and forecast, by Application

8.3.6.3 United Kingdom

8.3.6.3.1 Market size and forecast, by Technology

8.3.6.3.2 Market size and forecast, by Type

8.3.6.3.3 Market size and forecast, by Utility

8.3.6.3.4 Market size and forecast, by Application

8.3.6.4 Italy

8.3.6.4.1 Market size and forecast, by Technology

8.3.6.4.2 Market size and forecast, by Type

8.3.6.4.3 Market size and forecast, by Utility

8.3.6.4.4 Market size and forecast, by Application

8.3.6.5 Spain

8.3.6.5.1 Market size and forecast, by Technology

8.3.6.5.2 Market size and forecast, by Type

8.3.6.5.3 Market size and forecast, by Utility

8.3.6.5.4 Market size and forecast, by Application

8.3.6.6 Rest of Europe

8.3.6.6.1 Market size and forecast, by Technology

8.3.6.6.2 Market size and forecast, by Type

8.3.6.6.3 Market size and forecast, by Utility

8.3.6.6.4 Market size and forecast, by Application

8.4 Asia-Pacific

8.4.1 Key trends and opportunities

8.4.2 Asia-Pacific Market size and forecast, by Technology

8.4.3 Asia-Pacific Market size and forecast, by Type

8.4.4 Asia-Pacific Market size and forecast, by Utility

8.4.5 Asia-Pacific Market size and forecast, by Application

8.4.6 Asia-Pacific Market size and forecast, by country

8.4.6.1 China

8.4.6.1.1 Market size and forecast, by Technology

8.4.6.1.2 Market size and forecast, by Type

8.4.6.1.3 Market size and forecast, by Utility

8.4.6.1.4 Market size and forecast, by Application

8.4.6.2 Japan

8.4.6.2.1 Market size and forecast, by Technology

8.4.6.2.2 Market size and forecast, by Type

8.4.6.2.3 Market size and forecast, by Utility

8.4.6.2.4 Market size and forecast, by Application

8.4.6.3 India

8.4.6.3.1 Market size and forecast, by Technology

8.4.6.3.2 Market size and forecast, by Type

8.4.6.3.3 Market size and forecast, by Utility

8.4.6.3.4 Market size and forecast, by Application

8.4.6.4 Australia

8.4.6.4.1 Market size and forecast, by Technology

8.4.6.4.2 Market size and forecast, by Type

8.4.6.4.3 Market size and forecast, by Utility

8.4.6.4.4 Market size and forecast, by Application

8.4.6.5 Rest Of Asia Pacific

8.4.6.5.1 Market size and forecast, by Technology

8.4.6.5.2 Market size and forecast, by Type

8.4.6.5.3 Market size and forecast, by Utility

8.4.6.5.4 Market size and forecast, by Application

8.5 LAMEA

8.5.1 Key trends and opportunities

8.5.2 LAMEA Market size and forecast, by Technology

8.5.3 LAMEA Market size and forecast, by Type

8.5.4 LAMEA Market size and forecast, by Utility

8.5.5 LAMEA Market size and forecast, by Application

8.5.6 LAMEA Market size and forecast, by country

8.5.6.1 Brazil

8.5.6.1.1 Market size and forecast, by Technology

8.5.6.1.2 Market size and forecast, by Type

8.5.6.1.3 Market size and forecast, by Utility

8.5.6.1.4 Market size and forecast, by Application

8.5.6.2 Turkey

8.5.6.2.1 Market size and forecast, by Technology

8.5.6.2.2 Market size and forecast, by Type

8.5.6.2.3 Market size and forecast, by Utility

8.5.6.2.4 Market size and forecast, by Application

8.5.6.3 Saudi Arabia

8.5.6.3.1 Market size and forecast, by Technology

8.5.6.3.2 Market size and forecast, by Type

8.5.6.3.3 Market size and forecast, by Utility

8.5.6.3.4 Market size and forecast, by Application

8.5.6.4 South Africa

8.5.6.4.1 Market size and forecast, by Technology

8.5.6.4.2 Market size and forecast, by Type

8.5.6.4.3 Market size and forecast, by Utility

8.5.6.4.4 Market size and forecast, by Application

8.5.6.5 Rest of LAMEA

8.5.6.5.1 Market size and forecast, by Technology

8.5.6.5.2 Market size and forecast, by Type

8.5.6.5.3 Market size and forecast, by Utility

8.5.6.5.4 Market size and forecast, by Application

9.1. Introduction

9.2. Top winning strategies

9.3. Product Mapping of Top 10 Player

9.4. Competitive Dashboard

9.5. Competitive Heatmap

9.6. Key developments

10.1 Abbott Laboratories

10.1.1 Company overview

10.1.2 Company snapshot

10.1.3 Operating business segments

10.1.4 Product portfolio

10.1.5 Business performance

10.1.6 Key strategic moves and developments

10.2 AngioDynamics, Inc

10.2.1 Company overview

10.2.2 Company snapshot

10.2.3 Operating business segments

10.2.4 Product portfolio

10.2.5 Business performance

10.2.6 Key strategic moves and developments

10.3 Boston Scientific Group

10.3.1 Company overview

10.3.2 Company snapshot

10.3.3 Operating business segments

10.3.4 Product portfolio

10.3.5 Business performance

10.3.6 Key strategic moves and developments

10.4 Johnson and Johnson

10.4.1 Company overview

10.4.2 Company snapshot

10.4.3 Operating business segments

10.4.4 Product portfolio

10.4.5 Business performance

10.4.6 Key strategic moves and developments

10.5 Koninklijke Philips N.V.

10.5.1 Company overview

10.5.2 Company snapshot

10.5.3 Operating business segments

10.5.4 Product portfolio

10.5.5 Business performance

10.5.6 Key strategic moves and developments

10.6 Medtronic plc

10.6.1 Company overview

10.6.2 Company snapshot

10.6.3 Operating business segments

10.6.4 Product portfolio

10.6.5 Business performance

10.6.6 Key strategic moves and developments

10.7 Penumbra Inc.

10.7.1 Company overview

10.7.2 Company snapshot

10.7.3 Operating business segments

10.7.4 Product portfolio

10.7.5 Business performance

10.7.6 Key strategic moves and developments

10.8 Stryker Corporation

10.8.1 Company overview

10.8.2 Company snapshot

10.8.3 Operating business segments

10.8.4 Product portfolio

10.8.5 Business performance

10.8.6 Key strategic moves and developments

10.9 Teleflex Incorporated

10.9.1 Company overview

10.9.2 Company snapshot

10.9.3 Operating business segments

10.9.4 Product portfolio

10.9.5 Business performance

10.9.6 Key strategic moves and developments

10.10 Terumo Corporation

10.10.1 Company overview

10.10.2 Company snapshot

10.10.3 Operating business segments

10.10.4 Product portfolio

10.10.5 Business performance

10.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)

TABLE 2. THROMBECTOMY DEVICES MARKET REVENUE, FOR MECHANICAL THROMBECTOMY, BY REGION , 2020-2030,($MILLION)

TABLE 3. THROMBECTOMY DEVICES MARKET MECHANICAL THROMBECTOMY BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. THROMBECTOMY DEVICES MARKET REVENUE, FOR ASPIRATION THROMBECTOMY, BY REGION , 2020-2030,($MILLION)

TABLE 5. THROMBECTOMY DEVICES MARKET ASPIRATION THROMBECTOMY BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. THROMBECTOMY DEVICES MARKET REVENUE, FOR RHEOLYTIC THROMBECTOMY, BY REGION , 2020-2030,($MILLION)

TABLE 7. THROMBECTOMY DEVICES MARKET RHEOLYTIC THROMBECTOMY BY COUNTRY, 2020-2030,($MILLION)

TABLE 8. GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 9. THROMBECTOMY DEVICES MARKET REVENUE, FOR AUTOMATED DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 10. THROMBECTOMY DEVICES MARKET AUTOMATED DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. THROMBECTOMY DEVICES MARKET REVENUE, FOR MANUAL DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 12. THROMBECTOMY DEVICES MARKET MANUAL DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. GLOBAL THROMBECTOMY DEVICES MARKET, BY UTILITY, 2020-2030,($MILLION)

TABLE 14. THROMBECTOMY DEVICES MARKET REVENUE, FOR REUSABLE DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 15. THROMBECTOMY DEVICES MARKET REUSABLE DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 16. THROMBECTOMY DEVICES MARKET REVENUE, FOR DISPOSABLE DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 17. THROMBECTOMY DEVICES MARKET DISPOSABLE DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 18. GLOBAL THROMBECTOMY DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 19. THROMBECTOMY DEVICES MARKET REVENUE, FOR PERIPHERAL DISEASES, BY REGION , 2020-2030,($MILLION)

TABLE 20. THROMBECTOMY DEVICES MARKET PERIPHERAL DISEASES BY COUNTRY, 2020-2030,($MILLION)

TABLE 21. THROMBECTOMY DEVICES MARKET REVENUE, FOR CORONARY DISEASE, BY REGION , 2020-2030,($MILLION)

TABLE 22. THROMBECTOMY DEVICES MARKET CORONARY DISEASE BY COUNTRY, 2020-2030,($MILLION)

TABLE 23. THROMBECTOMY DEVICES MARKET REVENUE, FOR NEURAL DISEASES, BY REGION , 2020-2030,($MILLION)

TABLE 24. THROMBECTOMY DEVICES MARKET NEURAL DISEASES BY COUNTRY, 2020-2030,($MILLION)

TABLE 25. THROMBECTOMY DEVICES MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 26. NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)

TABLE 27. NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 28. NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY UTILITY, 2020-2030,($MILLION)

TABLE 29. NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 30. NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 31. U.S. THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 32. U.S. THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 33. U.S. THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 34. U.S. THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 35. CANADA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 36. CANADA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 37. CANADA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 38. CANADA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 39. MEXICO THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 40. MEXICO THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 41. MEXICO THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 42. MEXICO THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 43. EUROPE THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)

TABLE 44. EUROPE THROMBECTOMY DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 45. EUROPE THROMBECTOMY DEVICES MARKET, BY UTILITY, 2020-2030,($MILLION)

TABLE 46. EUROPE THROMBECTOMY DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 47. EUROPE THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 48. GERMANY THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 49. GERMANY THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 50. GERMANY THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 51. GERMANY THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 52. FRANCE THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 53. FRANCE THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 54. FRANCE THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 55. FRANCE THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 56. UNITED KINGDOM THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 57. UNITED KINGDOM THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 58. UNITED KINGDOM THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 59. UNITED KINGDOM THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 60. ITALY THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 61. ITALY THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 62. ITALY THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 63. ITALY THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 64. SPAIN THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 65. SPAIN THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 66. SPAIN THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 67. SPAIN THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 68. REST OF EUROPE THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 69. REST OF EUROPE THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 70. REST OF EUROPE THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 71. REST OF EUROPE THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 72. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)

TABLE 73. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 74. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY UTILITY, 2020-2030,($MILLION)

TABLE 75. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 76. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 77. CHINA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 78. CHINA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 79. CHINA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 80. CHINA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 81. JAPAN THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 82. JAPAN THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 83. JAPAN THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 84. JAPAN THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 85. INDIA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 86. INDIA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 87. INDIA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 88. INDIA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 89. AUSTRALIA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 90. AUSTRALIA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 91. AUSTRALIA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 92. AUSTRALIA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 93. REST OF ASIA PACIFIC THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 94. REST OF ASIA PACIFIC THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 95. REST OF ASIA PACIFIC THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 96. REST OF ASIA PACIFIC THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 97. LAMEA THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)

TABLE 98. LAMEA THROMBECTOMY DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 99. LAMEA THROMBECTOMY DEVICES MARKET, BY UTILITY, 2020-2030,($MILLION)

TABLE 100. LAMEA THROMBECTOMY DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 101. LAMEA THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 102. BRAZIL THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 103. BRAZIL THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 104. BRAZIL THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 105. BRAZIL THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 106. TURKEY THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 107. TURKEY THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 108. TURKEY THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 109. TURKEY THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 110. SAUDI ARABIA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 111. SAUDI ARABIA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 112. SAUDI ARABIA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 113. SAUDI ARABIA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 114. SOUTH AFRICA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 115. SOUTH AFRICA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 116. SOUTH AFRICA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 117. SOUTH AFRICA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 118. REST OF LAMEA THROMBECTOMY DEVICES MARKET BY TECHNOLOGY 2020-2030,($MILLION)

TABLE 119. REST OF LAMEA THROMBECTOMY DEVICES MARKET BY TYPE 2020-2030,($MILLION)

TABLE 120. REST OF LAMEA THROMBECTOMY DEVICES MARKET BY UTILITY 2020-2030,($MILLION)

TABLE 121. REST OF LAMEA THROMBECTOMY DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 122.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 123.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 124.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 125.ABBOTT LABORATORIES: NET SALES,

TABLE 126.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 127.ANGIODYNAMICS, INC: COMPANY SNAPSHOT

TABLE 128.ANGIODYNAMICS, INC: OPERATING SEGMENTS

TABLE 129.ANGIODYNAMICS, INC: PRODUCT PORTFOLIO

TABLE 130.ANGIODYNAMICS, INC: NET SALES,

TABLE 131.ANGIODYNAMICS, INC: KEY STRATERGIES

TABLE 132.BOSTON SCIENTIFIC GROUP: COMPANY SNAPSHOT

TABLE 133.BOSTON SCIENTIFIC GROUP: OPERATING SEGMENTS

TABLE 134.BOSTON SCIENTIFIC GROUP: PRODUCT PORTFOLIO

TABLE 135.BOSTON SCIENTIFIC GROUP: NET SALES,

TABLE 136.BOSTON SCIENTIFIC GROUP: KEY STRATERGIES

TABLE 137.JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 138.JOHNSON AND JOHNSON: OPERATING SEGMENTS

TABLE 139.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 140.JOHNSON AND JOHNSON: NET SALES,

TABLE 141.JOHNSON AND JOHNSON: KEY STRATERGIES

TABLE 142.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 143.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS

TABLE 144.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 145.KONINKLIJKE PHILIPS N.V.: NET SALES,

TABLE 146.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES

TABLE 147.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 148.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 149.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 150.MEDTRONIC PLC: NET SALES,

TABLE 151.MEDTRONIC PLC: KEY STRATERGIES

TABLE 152.PENUMBRA INC.: COMPANY SNAPSHOT

TABLE 153.PENUMBRA INC.: OPERATING SEGMENTS

TABLE 154.PENUMBRA INC.: PRODUCT PORTFOLIO

TABLE 155.PENUMBRA INC.: NET SALES,

TABLE 156.PENUMBRA INC.: KEY STRATERGIES

TABLE 157.STRYKER CORPORATION: COMPANY SNAPSHOT

TABLE 158.STRYKER CORPORATION: OPERATING SEGMENTS

TABLE 159.STRYKER CORPORATION: PRODUCT PORTFOLIO

TABLE 160.STRYKER CORPORATION: NET SALES,

TABLE 161.STRYKER CORPORATION: KEY STRATERGIES

TABLE 162.TELEFLEX INCORPORATED: COMPANY SNAPSHOT

TABLE 163.TELEFLEX INCORPORATED: OPERATING SEGMENTS

TABLE 164.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO

TABLE 165.TELEFLEX INCORPORATED: NET SALES,

TABLE 166.TELEFLEX INCORPORATED: KEY STRATERGIES

TABLE 167.TERUMO CORPORATION: COMPANY SNAPSHOT

TABLE 168.TERUMO CORPORATION: OPERATING SEGMENTS

TABLE 169.TERUMO CORPORATION: PRODUCT PORTFOLIO

TABLE 170.TERUMO CORPORATION: NET SALES,

TABLE 171.TERUMO CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.THROMBECTOMY DEVICES MARKET SEGMENTATION

FIGURE 2.THROMBECTOMY DEVICES MARKET,2020-2030

FIGURE 3.THROMBECTOMY DEVICES MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.THROMBECTOMY DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.THROMBECTOMY DEVICES MARKET,BY TECHNOLOGY,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF MECHANICAL THROMBECTOMY THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ASPIRATION THROMBECTOMY THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF RHEOLYTIC THROMBECTOMY THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 16.THROMBECTOMY DEVICES MARKET,BY TYPE,2020(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF AUTOMATED DEVICES THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MANUAL DEVICES THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 19.THROMBECTOMY DEVICES MARKET,BY UTILITY,2020(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF REUSABLE DEVICES THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE DEVICES THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 22.THROMBECTOMY DEVICES MARKET,BY APPLICATION,2020(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PERIPHERAL DISEASES THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF CORONARY DISEASE THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF NEURAL DISEASES THROMBECTOMY DEVICES MARKET,2020-2030(%)

FIGURE 26.THROMBECTOMY DEVICES MARKET BY REGION,2020

FIGURE 27.U.S. THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 28.CANADA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 29.MEXICO THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 30.GERMANY THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 31.FRANCE THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 32.UNITED KINGDOM THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 33.ITALY THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 34.SPAIN THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 35.REST OF EUROPE THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 36.CHINA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 37.JAPAN THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 38.INDIA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 39.AUSTRALIA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 40.REST OF ASIA PACIFIC THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 41.BRAZIL THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 42.TURKEY THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 43.SAUDI ARABIA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 44.SOUTH AFRICA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 45.REST OF LAMEA THROMBECTOMY DEVICES MARKET,2020-2030($MILLION)

FIGURE 46. TOP WINNING STRATEGIES, BY YEAR

FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 50.COMPETITIVE DASHBOARD

FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 52.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 53.ANGIODYNAMICS, INC.: NET SALES ,($MILLION)

FIGURE 54.BOSTON SCIENTIFIC GROUP.: NET SALES ,($MILLION)

FIGURE 55.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)

FIGURE 56.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)

FIGURE 57.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 58.PENUMBRA INC..: NET SALES ,($MILLION)

FIGURE 59.STRYKER CORPORATION.: NET SALES ,($MILLION)

FIGURE 60.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)

FIGURE 61.TERUMO CORPORATION.: NET SALES ,($MILLION